SABCS 2021: EMERALD Reveals Promise of Elacestrant for ER-Positive/HER2-Negative Metastatic Breast Cancer
Author suspects the agent could become a new standard of care in this setting
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.